Prismasol 4 mmol/l Potassium, Hämofiltrations- und Hämodialyselösung

7680586090041 CH-58609 Hämofiltrations- und Hämodialyselösung
Prismasol 4 mmol/l Potassium, Hämofiltrations- und Hämodialyselösung
Prismasol 4 mmol/l Potassium, Hämofiltrations- und Hämodialyselösung
Prismasol 4 mmol/l Potassium, Hämofiltrations- und Hämodialyselösung
1 / 3
google

Article details

Package size
2 x 5000
Selling units
2
Measure
ml
Galenic form
Hämofiltrations- und Hämodialyselösung
Galenic group
Dialyse

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/03/2025
Summary of Product Characteristics
Français
14/03/2025

Detailed composition

Substance Quantity Type Category
calcii chloridum dihydricum
0.257 G Substance Wirkstoff (Principe actif)
magnesii chloridum hexahydricum
0.102 G Substance Wirkstoff (Principe actif)
calcii chloridum dihydricum
5.145 G Substance Wirkstoff (Principe actif)
magnesii chloridum hexahydricum
2.033 G Substance Wirkstoff (Principe actif)
glucosum
1.1 G Substance Wirkstoff (Principe actif)
glucosum
22.0 G Substance Wirkstoff (Principe actif)
glucosum monohydricum
- Substance WIZUS
acidum (S)-lacticum
0.27 G Substance Wirkstoff (Principe actif)
glucosum monohydricum
- Substance WIZUS
natrii chloridum
6.128 G Substance Wirkstoff (Principe actif)
acidum lacticum
5.4 G Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrii hydrogenocarbonas
2.936 G Substance Wirkstoff (Principe actif)
kalii chloridum
0.298 G Substance Wirkstoff (Principe actif)
natrii chloridum
6.45 G Substance Wirkstoff (Principe actif)
natrii hydrogenocarbonas
3.09 G Substance Wirkstoff (Principe actif)
kalii chloridum
0.314 G Substance Wirkstoff (Principe actif)
calcium
1.75 MMOLL Substance Wirkstoff (Principe actif)
magnesium
0.5 MMOLL Substance Wirkstoff (Principe actif)
carbonei dioxidum
- Substance TRGAS
natrium
140.0 MMOLL Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
chloridum
113.5 MMOLL Substance Wirkstoff (Principe actif)
(S)-lactas
3.0 MMOLL Substance Wirkstoff (Principe actif)
hydrogenocarbonas
32.0 MMOLL Substance Wirkstoff (Principe actif)
kalium
4.0 MMOLL Substance Wirkstoff (Principe actif)
glucosum
6.1 MMOLL Substance Wirkstoff (Principe actif)

Authorization holder

Vantive GmbH

8152 Opfikon

Authorization information

Swissmedic authorization number
58609
Drug name
Prismasol, Hämofiltrations- und Hämodialyselösung
Galenic form
HADF
ATC Code
B05ZB
Authorization status
Z
Dispensing category
B
First authorization
19/09/2008
Authorization expiration date
31/12/9999
IT Number
05.04.0.
Domain
Human medicine
Field of application
Hämofiltration

Package details

Description (FR)
PRISMASOL 4 mmol/l Potassium sol 2x5000 ml
Description (DE)
PRISMASOL 4 mmol/l Potassium Lös 2x5000 ml
Market launch
01/03/2025
Narcotic (BTM)
No

Other package sizes (3)

None
2 x 5000 ML
GTIN: None
Not in V1
None
2 x 5000 ML
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
Buy us a coffee Explore the data